TrademarkDir
DTX PHARMA
DEAD

Serial Number

97249797

Owner

DTx Pharma, Inc.

Attorney

Maury M. Tepper, III

Filing Date

Feb 2, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DTX PHARMA Trademark

Serial Number: 97249797

DTX PHARMA is a trademark filed by DTx Pharma, Inc. on February 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

DTx Pharma, Inc. (2 trademarks)

10655 Sorrento Valley Road, Suite 100
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

February 2, 2022

Registration Date

Not Registered

Published for Opposition

May 23, 2023

Goods & Services

Pharmaceutical preparations, namely, oligonucleotide compounds; oligonucleotide compounds for the treatment of genetic diseases; oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases; therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases; fatty acid-based oligonucleotide delivery agents in the form of intravenous infusion or injection, suspension or sterile powder for the treatment of genetic diseases

Pharmaceutical research and development of oligonucleotide compounds; scientific research and product development in the field of oligonucleotide compounds and drug discovery; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in therapeutic discovery and development; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in the treatment of genetic diseases; Pharmaceutical research and development of therapeutic preparations using RNA to treat ocular, neuromuscular and central nervous system (CNS) diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 23, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 23, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jul 14, 2025 EX4G
SOU EXTENSION 4 FILED
Jul 14, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 14, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 14, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 14, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 14, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 11, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 11, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 11, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 8, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 8, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 12, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 12, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 12, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 12, 2023 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 24, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 24, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 24, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2022 NWOS
NEW APPLICATION ENTERED
Feb 5, 2022 NWAP

Related Trademarks

More from this Owner

FALCON

FALCON